{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:47:39Z","timestamp":1792842459959,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["NO.2021PT-038"],"award-info":[{"award-number":["NO.2021PT-038"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2021PT-038"],"award-info":[{"award-number":["2021PT-038"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100649"],"award-info":[{"award-number":["32100649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070649"],"award-info":[{"award-number":["82070649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.cellsig.2025.111684","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T17:40:35Z","timestamp":1740332435000},"page":"111684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Epigenetics in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"130","author":[{"given":"Yanru","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruike","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangshuo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cellsig.2025.111684_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2025.111684_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2023.03.013","article-title":"DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates","volume":"35","author":"Qu","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","article-title":"Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet","volume":"51","author":"Pogribny","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cellsig.2025.111684_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"7648","key":"10.1016\/j.cellsig.2025.111684_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature21429","article-title":"3D structures of individual mammalian genomes studied by single-cell hi-C","volume":"544","author":"Stevens","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41467-020-14796-x","article-title":"Alterations in promoter interaction landscape and transcriptional network underlying metabolic adaptation to diet","volume":"11","author":"Qin","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0045","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jcmgh.2021.07.016","article-title":"Liver-specific deletion of mouse CTCF leads to hepatic steatosis via augmented PPAR\u03b3 signaling","volume":"12","author":"Choi","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.cellsig.2025.111684_bb0050","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/j.apsb.2021.03.022","article-title":"3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated hi-C, nanopore, and RNA sequencing","volume":"11","author":"Xu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111684_bb0055","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41596-022-00692-9","article-title":"Chromatin accessibility profiling by ATAC-seq","volume":"17","author":"Grandi","year":"2022","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111684_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.04.001","article-title":"Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis","volume":"52","author":"Seidman","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0065","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/s41467-021-27539-3","article-title":"The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0070","doi-asserted-by":"crossref","first-page":"343","DOI":"10.14348\/molcells.2022.0001","article-title":"The chromatin accessibility landscape of nonalcoholic fatty liver disease progression","volume":"45","author":"Kang","year":"2022","journal-title":"Mol. Cell"},{"issue":"10","key":"10.1016\/j.cellsig.2025.111684_bb0075","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301988","article-title":"Gene-regulation modules in nonalcoholic fatty liver disease revealed by single-nucleus ATAC-seq","volume":"6","author":"Takeuchi","year":"2023","journal-title":"Life Sci. Alliance"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020689","article-title":"Paternal methyl donor supplementation in rats improves fertility, physiological outcomes, gut microbial signatures and epigenetic markers altered by high fat\/high sucrose diet","volume":"22","author":"Chleilat","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111684_bb0085","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mnfr.201000300","article-title":"Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet","volume":"55","author":"Tryndyak","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111684_bb0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/liv.13249","article-title":"Nonalcoholic steatohepatitis is associated with a state of betaine-insufficiency","volume":"37","author":"Sookoian","year":"2017","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0105","article-title":"DNA methylation of SMPD3-based diagnostic biomarkers of NASH and mild fibrosis","volume":"11","author":"Wu","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.cellsig.2025.111684_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121951","article-title":"Whole-genome DNA methylation and gene expression profiling in the livers of mice with nonalcoholic steatohepatitis","volume":"329","author":"Bi","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13148-023-01431-x","article-title":"Liver saturated fat content associates with hepatic DNA methylation in obese individuals","volume":"15","author":"Sehgal","year":"2023","journal-title":"Clin. Epigenetics"},{"issue":"614","key":"10.1016\/j.cellsig.2025.111684_bb0120","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd1206","article-title":"Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111684_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116263","article-title":"Betaine alleviates high-fat diet-induced Disruptionof hepatic lipid and Iron homeostasis in mice","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0130","first-page":"1215","article-title":"Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with non-alcoholic fatty liver disease","volume":"42","author":"Cai","year":"2018","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0135","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13073-022-01071-5","article-title":"Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease","volume":"14","author":"Assante","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.cellsig.2025.111684_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep40220","article-title":"High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss","volume":"7","author":"Siersb\u00e6k","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellsig.2025.111684_bb0145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2013.07.011","article-title":"Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation","volume":"59","author":"Cao","year":"2013","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/14728222.2016.1153067","article-title":"Protective role of silent information regulator 1 against hepatic ischemia: effects on oxidative stress injury, inflammatory response, and MAPKs","volume":"20","author":"Yang","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2010.06.009","article-title":"Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis","volume":"12","author":"Kim","year":"2010","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111684_bb0160","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cmet.2014.03.006","article-title":"SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway","volume":"19","author":"Yoshizawa","year":"2014","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12937-4","article-title":"Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice","volume":"12","author":"Al-Griw","year":"2022","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111684_bb0170","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/jgh.16252","article-title":"Removal of epigenetic repressive mark on inflammatory genes in fat liver","volume":"38","author":"Zhang","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111684_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044345","article-title":"Hepatic lipid accumulation alters global histone h3 lysine 9 and 4 trimethylation in the peroxisome proliferator-activated receptor alpha network","volume":"7","author":"Jun","year":"2012","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"10.1016\/j.cellsig.2025.111684_bb0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbrc.2022.05.098","article-title":"Kaempferol antagonizes adipogenesis by repressing histone H3K4 methylation at PPAR\u03b3 target genes","volume":"617","author":"Park","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0185","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1096\/fj.14-262717","article-title":"MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis","volume":"29","author":"Podrini","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18632\/aging.100632","article-title":"SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation","volume":"6","author":"Pazienza","year":"2014","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0200","article-title":"The role of the histone methyltransferase EZH2 in liver inflammation and fibrosis in STAM NASH mice","volume":"9","author":"Lee","year":"2020","journal-title":"Biology (Basel)"},{"issue":"6","key":"10.1016\/j.cellsig.2025.111684_bb0205","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.celrep.2016.10.023","article-title":"Critical roles of the histone methyltransferase MLL4\/KMT2D in murine hepatic steatosis directed by ABL1 and PPAR\u03b32","volume":"17","author":"Kim","year":"2016","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.cellsig.2025.111684_bb0210","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41374-021-00626-1","article-title":"Steatosis, inflammasome upregulation, and fibrosis are attenuated in miR-155 deficient mice in a high fat-cholesterol-sugar diet-induced model of NASH","volume":"101","author":"Bala","year":"2021","journal-title":"Lab. Investig."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0215","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111684_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNAs \u2212122, \u2212192 and \u221221 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0225","first-page":"C588","article-title":"Circulating miRNAs associated with nonalcoholic fatty liver disease","volume":"324","author":"Atic","year":"2023","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0230","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/obr.12765","article-title":"Adipose may actively delay progression of NAFLD by releasing tumor-suppressing, anti-fibrotic miR-122 into circulation","volume":"20","author":"Baranova","year":"2019","journal-title":"Obes. Rev."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0235","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/liv.12633","article-title":"microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis","volume":"35","author":"Csak","year":"2015","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0240","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA attenuates nonalcoholic fatty liver progression in mice via up-regulation of MicroRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.cellsig.2025.111684_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.05.008","article-title":"MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0250","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jhep.2023.06.019","article-title":"Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2","volume":"79","author":"Li","year":"2023","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0255","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/jgh.12878","article-title":"MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice","volume":"30","author":"Jiang","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.cellsig.2025.111684_bb0260","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301902","article-title":"Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis","volume":"6","author":"Miyagawa","year":"2023","journal-title":"Life Sci. Alliance"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0265","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12967-022-03543-z","article-title":"Modulation of hepatic stellate cells by Mutaflor\u00ae probiotic in non-alcoholic fatty liver disease management","volume":"20","author":"Hany","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cellsig.2025.111684_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111781","article-title":"Probiotic-prebiotic-synbiotic modulation of (YAP1, LATS1 and NF2 mRNAs\/miR-1205\/lncRNA SRD5A3-AS1) panel in NASH animal model","volume":"140","author":"Gadallah","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0275","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.27153","article-title":"Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia","volume":"60","author":"Ng","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.07.048","article-title":"miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder","volume":"74","author":"Fan","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0285","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1038\/s41467-022-35481-1","article-title":"Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease","volume":"13","author":"Lekka","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0290","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.aohep.2019.12.003","article-title":"Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing","volume":"19","author":"Zhang","year":"2020","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111684_bb0295","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ijo.2017.21","article-title":"Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD","volume":"41","author":"Latorre","year":"2017","journal-title":"Int. J. Obes."},{"issue":"22","key":"10.1016\/j.cellsig.2025.111684_bb0300","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"D\u00e1valos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24020230","article-title":"MicroRNAs as a novel tool in the diagnosis of liver lipid dysregulation and fatty liver disease","volume":"24","author":"Yu","year":"2019","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.cellsig.2025.111684_bb0310","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1136\/gutjnl-2011-300717","article-title":"MicroRNA-221\/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis","volume":"61","author":"Ogawa","year":"2012","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.cellsig.2025.111684_bb0315","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121751","article-title":"Ability of a combined FIB4\/miRNA181a score to predict significant liver fibrosis in NAFLD patients","volume":"9","author":"Lima","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/2211536607666180531093302","article-title":"Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD)","volume":"7","author":"Jampoka","year":"2018","journal-title":"Microrna"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111684_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12967-021-02769-7","article-title":"LncRNA-Gm9795 promotes inflammation in non-alcoholic steatohepatitis via NF-[formula: see text]B\/JNK pathway by endoplasmic reticulum stress","volume":"19","author":"Ye","year":"2021","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0335","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7150\/thno.50281","article-title":"Oscillating lncRNA Platr4 regulates NLRP3 inflammasome to ameliorate nonalcoholic steatohepatitis in mice","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2025.111684_bb0340","first-page":"190","article-title":"Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells","author":"Leti","year":"2017","journal-title":"Transl. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0345","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/hep.29034","article-title":"A liver-specific long noncoding RNA with a role in cell viability is elevated in human nonalcoholic steatohepatitis","volume":"66","author":"Atanasovska","year":"2017","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111684_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells10081883","article-title":"Long non-coding RNAs involved in progression of non-alcoholic fatty liver disease to steatohepatitis","volume":"10","author":"Atanasovska","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0355","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41467-018-05383-2","article-title":"Long noncoding RNA licensing of obesity-linked hepatic lipogenesis and NAFLD pathogenesis","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0360","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41467-018-03072-8","article-title":"Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195\/miR4668 maturation","volume":"9","author":"Guo","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2025.111684_bb0365","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jare.2022.08.007","article-title":"Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling","volume":"48","author":"Duan","year":"2023","journal-title":"J. Adv. Res."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0370","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","article-title":"Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy","volume":"11","author":"Jin","year":"2020","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111684_bb0375","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41419-021-04090-z","article-title":"Circ_0057558 promotes nonalcoholic fatty liver disease by regulating ROCK1\/AMPK signaling through targeting miR-206","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2025.111684_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021297","article-title":"CircRNA-PI4KB induces hepatic lipid deposition in non-alcoholic fatty liver disease by transporting miRNA-122 to extra-hepatocytes","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0385","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12951-021-01108-8","article-title":"A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p\/miR-320a and ABCA1\/CPT1 axis","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"23","key":"10.1016\/j.cellsig.2025.111684_bb0390","doi-asserted-by":"crossref","first-page":"23996","DOI":"10.18632\/aging.104081","article-title":"Hsa_circ_0048179 attenuates free fatty acid-induced steatosis via hsa_circ_0048179\/miR-188-3p\/GPX4 signaling","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.cellsig.2025.111684_bb0395","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3748\/wjg.v24.i3.323","article-title":"circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling","volume":"24","author":"Guo","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0400","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12944-022-01740-9","article-title":"CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease","volume":"21","author":"Yuan","year":"2022","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.cellsig.2025.111684_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.07.014","article-title":"Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11","author":"Zhou","year":"2024","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0410","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41392-024-01837-w","article-title":"Unraveling the role of METTL14 in metabolic dysfunction-associated fatty liver disease: insights and therapeutic implications","volume":"9","author":"Kim","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2025.111684_bb0415","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac061","article-title":"Aberrant elevation of FTO levels promotes liver steatosis by decreasing the m6A methylation and increasing the stability of SREBF1 and ChREBP mRNAs","volume":"14","author":"Tang","year":"2023","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.cellsig.2025.111684_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.989353","article-title":"FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA","volume":"12","author":"Gan","year":"2022","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.cellsig.2025.111684_bb0425","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jhep.2023.06.021","article-title":"Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis","volume":"79","author":"Wang","year":"2023","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.cellsig.2025.111684_bb0430","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0435","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13059-017-1187-1","article-title":"Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism","volume":"18","author":"Hahn","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.cellsig.2025.111684_bb0440","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2016.10.003","article-title":"Influence of maternal obesity, diet and exercise on epigenetic regulation of adipocytes","volume":"54","author":"Dhasarathy","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.cellsig.2025.111684_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154873","article-title":"Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk","volume":"124","author":"van den Hoek","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0450","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13578-021-00701-6","article-title":"Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation","volume":"11","author":"Wu","year":"2021","journal-title":"Cell Biosci."},{"issue":"4","key":"10.1016\/j.cellsig.2025.111684_bb0455","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12863","article-title":"Paternal sleep deprivation induces metabolic perturbations in male offspring via altered LRP5 DNA methylation of pancreatic islets","volume":"74","author":"Zeng","year":"2023","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0460","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13148-022-01284-w","article-title":"The mediating effect of DNA methylation in the association between maternal sleep during pregnancy and offspring adiposity status: a prospective cohort study","volume":"14","author":"Meng","year":"2022","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.cellsig.2025.111684_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2021.112256","article-title":"Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants","volume":"217","author":"Zhang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.cellsig.2025.111684_bb0470","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13148-022-01301-y","article-title":"DNA methylation: a potential mediator between air pollution and metabolic syndrome","volume":"14","author":"Poursafa","year":"2022","journal-title":"Clin. Epigenetics"},{"issue":"8","key":"10.1016\/j.cellsig.2025.111684_bb0475","doi-asserted-by":"crossref","DOI":"10.1289\/EHP664","article-title":"Hepatic lipid accumulation and Nrf2 expression following perinatal and Peripubertal exposure to bisphenol a in a mouse model of nonalcoholic liver disease","volume":"125","author":"Shimpi","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cellsig.2025.111684_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.127360","article-title":"In utero exposure to phenanthrene induces hepatic steatosis in F1 adult female mice","volume":"258","author":"Guo","year":"2020","journal-title":"Chemosphere"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089865682500097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:36:40Z","timestamp":1778701000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089865682500097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":96,"alternative-id":["S089865682500097X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111684","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetics in metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.111684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111684"}}